Growth of counterfeit medicines within the global supply chain has led to legislation (EU Falsified Medicines Directive) being introduced to maintain integrity of all pharmaceutical products manufactured and exported globally. METTLER TOLEDO’s latest white paper Serialisation of Pharmaceuticals – A Key to Success for the Pharma Industry outlines the evolving obligations affecting mandatory serialisation across different countries and regions. Outlined in the paper is an integrated workflow programme which helps manufacturers to maintain a consistent and transparent production process under the legislation. Also discussed are steps to help overcome the challenge of handling the large volumes of data a serialisation programme creates. Those responsible for defining the needs of or implementing a programme compliant to the latest standards will find it particularly useful.